Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 87.50
+0.90 (1.04%)
Jul 30, 2026, 1:09 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.35 billion as of July 29, 2026. Its market cap has decreased by -23.02% in one year.
Market Cap
2.35B
Enterprise Value
2.30B
Revenue
2.05B
Ranking
n/a
PE Ratio
10.40
Stock Price
87.50
ChartMarket Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.35B, an increase of 530.90%. That is a compound annual growth rate of 8.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.35B | -25.34% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.76B |
| BRIM Biotechnology | 2.75B |
| Energenesis Biomedical CO.,LTD. | 2.66B |
| Great Novel Therapeutics Biotech & Medicals | 2.62B |
| Chunghwa Chemical Synthesis & Biotech | 2.50B |
| GlycoNex Incorporation | 2.48B |
| Taiwan Bio Therapeutics | 2.19B |
| Sunhawk Vision Biotech | 2.08B |